Furthermore, a recombinant ADV expressing granulocyte-macrophage colony-stimulating factor (GMCSF) in combination with immune checkpoint inhibitors (ICIs) was able to control tumor growth in vivo and promote increased survival compared to control-treated animals [121]. Here, CSF2 is linked to neoplasm.